Next report date
Report period
H1 2024
EPS estimate
−1.55EUR
Revenue estimate
2.35 MEUR
−3.43EUR
−147.74 MEUR
45.89 M
About ABIVAX
Sector
CEO
Marc M. P. de Garidel
Headquarters
Paris
Website
Employees (FY)
61
Founded
2013
ISIN
FR0012333284
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2X1 is 13.94 EUR — it has increased by 1.16% in the past 24 hours. Watch ABIVAX SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ABIVAX SA stocks are traded under the ticker 2X1.
ABIVAX SA is going to release the next earnings report on Sep 9, 2024. Keep track of upcoming events with our Earnings Calendar.
2X1 stock is 1.88% volatile and has beta coefficient of 1.32. Track ABIVAX SA stock price on the chart and check out the list of the most volatile stocks — is ABIVAX SA there?
Yes, you can track ABIVAX SA financials in yearly and quarterly reports right on TradingView.
2X1 stock has fallen by 5.43% compared to the previous week, the month change is a 4.34% rise, over the last year ABIVAX SA has showed a 7.31% decrease.
2X1 net income for the last quarter is −95.79 M EUR, while the quarter before that showed −51.95 M EUR of net income which accounts for −84.37% change. Track more ABIVAX SA financial stats to get the full picture.
Today ABIVAX SA has the market capitalization of 869.52 M, it has increased by 6.94% over the last week.
No, 2X1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2X1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABIVAX SA stock right from TradingView charts — choose your broker and connect to your account.
As of May 3, 2024, the company has 61.00 employees. See our rating of the largest employees — is ABIVAX SA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABIVAX SA technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABIVAX SA stock shows the neutral signal. See more of ABIVAX SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ABIVAX SA future price: according to them, 2X1 price has a max estimate of 46.82 EUR and a min estimate of 14.95 EUR. Watch 2X1 chart and read a more detailed ABIVAX SA stock forecast: see what analysts think of ABIVAX SA and suggest that you do with its stocks.